Lennham Pharmaceuticals helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry.
Lennham Pharmaceuticals has raised $1.2M in total funding. The most recent round was Debt Financing. The last funding was announced in April 2023.
Lennham Pharmaceuticals is headquartered in Concord, United States.
Lennham Pharmaceuticals helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry.
Lennham Pharmaceuticals is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lennham Pharmaceuticals — Funding & Investors." VCBacked, April 3, 2023, https://www.vcbacked.co/company/lennham-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2023). Lennham Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/lennham-pharmaceuticals
{{cite web |title=Lennham Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/lennham-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated